- Recent Funding
- Investors
- Sanofi Ventures
Sanofi Ventures portfolio
Sanofi Ventures has 22 portfolio companies on record at Recent Funding, with 7 investments in the last 12 months.
About this page
It is a corporate venture investor based in Cambridge, US, founded in 2001. It led 8 of the 26 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (22) and Education (1). It has co-invested with Samsara Biocapital, Sofinnova Partners and Digitalis Ventures, most often Samsara Biocapital (7 rounds).
About Sanofi Ventures
What Sanofi Ventures invests in
- Health and bio · 22 · 100%
- Education · 1 · 5%
- Manufacturing and industrial · 1 · 5%
- Consumer and social · 1 · 5%
- Data and analytics · 1 · 5%
- Logistics and mobility · 1 · 5%
Sanofi Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $133M | Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation +6 | ||
| Series B+ · $310M | Jefferson Life Sciences, Novo Holdings (lead), Janus Henderson Investors +6 | ||
| Series B+ · $150M | Access Biotechnology, Digitalis Ventures, BOLD Longevity Growth Fund +6 | ||
| Series B+ · $66M | Redmile Group, NEA, Samsara Biocapital +6 | ||
| Series B+ · $90M | Janus Henderson Investors (lead), Duquesne Family Office, Octagon Capital Advisors (lead) +5 | ||
| Series B+ · $315M | Fidelity Management & Research Company, Morningside, Eli Lilly +15 | ||
| Series A · $165M | Apollo Health Ventures, Jeito Capital (lead), LMO +4 | ||
| Series A · $91M | Digitalis Ventures, Cambridge Innovation Capital, Cambridge Enterprise Ventures +4 |
How Sanofi Ventures invests
Sanofi Ventures portfolio companies
TT-Therapeutics$133MSeries B+ · Nov 2026
OOMass Therapeutics$310MSeries B+ · Oct 2026
MMatchpoint Therapeutics$150MSeries B+ · Oct 2026
AAbcuro$66MSeries B+ · Aug 2026
EEpicrispr Biotechnologies$90MSeries B+ · Aug 2026
AAdvanCell$315MSeries B+ · Jul 2026
BBionyra$165MSeries A · Jun 2026
SStar Therapeutics$125MSeries B+ · Oct 2025
SSplice Bio$140MSeries B+ · Jun 2025
TTherini Bio$39MSeries A · May 2025
GGlycomine$115MSeries B+ · May 2025
NNormunity$75MSeries B+ · Jan 2025
NNura Bio$68MSeries A · Sep 2024
MMirador Therapeutics$400MSeries A · Mar 2024
CClick TherapeuticsSeries B+ · Oct 2021
DDraig Therapeuticsbacker
ZZag Biobacker
CCharacter Biobacker
LLifordi Immunotherapeuticsbacker
GGranite Biobacker
CCurevo Vaccinebacker
WWindward Biobacker
| Company | Round with Sanofi Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $133M | $283M | Nov 5, 2026 Series B+ |
Health and bio |
Series B+ · $310M | $422.51M | Oct 15, 2026 Series B+ |
Health and bio |
Series B+ · $150M | $250M | Oct 7, 2026 Series B+ |
Health and bio |
Series B+ · $66M | $463M | Aug 18, 2026 Series B+ |
Health and bio |
Series B+ · $90M | $158M | Aug 11, 2026 Series B+ |
Health and bio |
Series B+ · $315M | $439.5M | Jul 15, 2026 Series B+ |
Health and bio |
Series A · $165M | $165M | Jun 22, 2026 Series A |
Health and bio |
Series B+ · $125M · lead | $415M | Oct 23, 2026 Series B+ |
Health and bio |
Series B+ · $140M · lead | $197M | Jun 11, 2025 Series B+ |
Health and bio |
Series A · $39M | $56M | May 21, 2026 Series A |
Health and bio |
Series B+ · $115M | $195M | May 9, 2025 Series B+ |
Health and bio |
Series B+ · $75M | $140M | Jan 13, 2025 Series B+ |
Health and bio |
Series A · $68M | $141.8M | Jun 22, 2026 Series B+ |
Health and bio |
Series A · $400M | $650M | Jan 13, 2026 Series B+ |
Health and bio |
Series B+ | $50M | Apr 13, 2026 Series B+ |
Health and bio |
backer | $205M | Jul 14, 2026 Series B+ |
Health and bio |
backer | undisclosed | — |
Health and bio |
backer | $111M | Mar 25, 2025 Series B+ |
Health and bio |
backer | undisclosed | Nov 18, 2025 Series A |
Health and bio |
backer | $30M | Apr 25, 2025 Series A |
Health and bio |
backer | undisclosed | Mar 18, 2025 Series B+ |
Health and bio |
backer | $200M | May 5, 2026 round |
Most frequent co-investors
SSamsara Biocapital7 shared rounds · last Nov 5, 2026
SSofinnova Partners5 shared rounds · last Nov 5, 2026
DDigitalis Ventures5 shared rounds · last Nov 5, 2026
SSV Health Investors5 shared rounds · last Oct 15, 2026
RRA Capital Management5 shared rounds · last Aug 18, 2026
RRedmile Group4 shared rounds · last Aug 18, 2026
SSoleus Capital4 shared rounds · last Aug 18, 2026
PPontifax4 shared rounds · last Aug 18, 2026
AAbingworth4 shared rounds · last Jul 15, 2026
FF-Prime Capital3 shared rounds · last Nov 5, 2026
CCambridge Innovation Capital3 shared rounds · last Nov 5, 2026
NNovo Holdings3 shared rounds · last Oct 15, 2026
Similar investors
MM Ventures21 companies · 7 deals in 12 mo
NNovartis Venture Fund21 companies · 3 deals in 12 mo
PPfizer Venture Investments20 companies · 6 deals in 12 mo
OOptum Ventures16 companies · 4 deals in 12 mo
AAngelini Ventures14 companies · 4 deals in 12 mo
MMitsubishi UFJ Capital37 companies · 10 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 26 rounds on Recent Funding that name Sanofi Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Sanofi Ventures, which is a subset of its real portfolio. API: /api/v1/investors/sanofi-ventures (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy